Branded Drug Makers Criticize E.U. Deal on Data Protection, Generics
European drugmakers raised concerns about moves in the European Parliament to limit the data protection period for new drugs and water down the definition of generic versions, newswires reported....To view the full article, register now.
Already a subscriber? Click here to view full article